{
  "20150305_QEp7_FaCo_SA_CL_OVCAR3_A.raw": {
    "Source Name": [
      "OVCAR3"
    ],
    "Assay Name": [
      "OVCAR3_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVCAR3_A.raw"
    ],
    "Characteristics[CellLine]": [
      "OVCAR3"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_COV318_B.raw": {
    "Source Name": [
      "COV318"
    ],
    "Assay Name": [
      "COV318_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_COV318_B.raw"
    ],
    "Characteristics[CellLine]": [
      "COV318"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_JHOS2_A.raw": {
    "Source Name": [
      "JHOS2"
    ],
    "Assay Name": [
      "JHOS2_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_JHOS2_A.raw"
    ],
    "Characteristics[CellLine]": [
      "JHOS2"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_HEYA8_A.raw": {
    "Source Name": [
      "HEYA8"
    ],
    "Assay Name": [
      "HEYA8_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_HEYA8_A.raw"
    ],
    "Characteristics[CellLine]": [
      "HEYA8"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVCAR3_B.raw": {
    "Source Name": [
      "OVCAR3"
    ],
    "Assay Name": [
      "OVCAR3_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVCAR3_B.raw"
    ],
    "Characteristics[CellLine]": [
      "OVCAR3"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_HEYA8_B.raw": {
    "Source Name": [
      "HEYA8"
    ],
    "Assay Name": [
      "HEYA8_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_HEYA8_B.raw"
    ],
    "Characteristics[CellLine]": [
      "HEYA8"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVKATE_C.raw": {
    "Source Name": [
      "OVKATE"
    ],
    "Assay Name": [
      "OVKATE_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVKATE_C.raw"
    ],
    "Characteristics[CellLine]": [
      "OVKATE"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20130607_EXQ4_FaCo_SA_CL_A2780_A.raw": {
    "Source Name": [
      "A2780"
    ],
    "Assay Name": [
      "A2780_A"
    ],
    "Raw Data File": [
      "20130607_EXQ4_FaCo_SA_CL_A2780_A.raw"
    ],
    "Characteristics[CellLine]": [
      "A2780"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20130607_EXQ4_FaCo_SA_CL_A2780_B.raw": {
    "Source Name": [
      "A2780"
    ],
    "Assay Name": [
      "A2780_B"
    ],
    "Raw Data File": [
      "20130607_EXQ4_FaCo_SA_CL_A2780_B.raw"
    ],
    "Characteristics[CellLine]": [
      "A2780"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVKATE_A.raw": {
    "Source Name": [
      "OVKATE"
    ],
    "Assay Name": [
      "OVKATE_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVKATE_A.raw"
    ],
    "Characteristics[CellLine]": [
      "OVKATE"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVCAR5_A.raw": {
    "Source Name": [
      "OVCAR5"
    ],
    "Assay Name": [
      "OVCAR5_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVCAR5_A.raw"
    ],
    "Characteristics[CellLine]": [
      "OVCAR5"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVCAR5_C.raw": {
    "Source Name": [
      "OVCAR5"
    ],
    "Assay Name": [
      "OVCAR5_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVCAR5_C.raw"
    ],
    "Characteristics[CellLine]": [
      "OVCAR5"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVKATE_B.raw": {
    "Source Name": [
      "OVKATE"
    ],
    "Assay Name": [
      "OVKATE_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVKATE_B.raw"
    ],
    "Characteristics[CellLine]": [
      "OVKATE"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVSAHO_A.raw": {
    "Source Name": [
      "OVSAHO"
    ],
    "Assay Name": [
      "OVSAHO_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVSAHO_A.raw"
    ],
    "Characteristics[CellLine]": [
      "OVSAHO"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_CAOV3_B.raw": {
    "Source Name": [
      "CAOV3"
    ],
    "Assay Name": [
      "CAOV3_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_CAOV3_B.raw"
    ],
    "Characteristics[CellLine]": [
      "CAOV3"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_JHOS2_B.raw": {
    "Source Name": [
      "JHOS2"
    ],
    "Assay Name": [
      "JHOS2_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_JHOS2_B.raw"
    ],
    "Characteristics[CellLine]": [
      "JHOS2"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_COV318_A.raw": {
    "Source Name": [
      "COV318"
    ],
    "Assay Name": [
      "COV318_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_COV318_A.raw"
    ],
    "Characteristics[CellLine]": [
      "COV318"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_JHOS4_C.raw": {
    "Source Name": [
      "JHOS4"
    ],
    "Assay Name": [
      "JHOS4_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_JHOS4_C.raw"
    ],
    "Characteristics[CellLine]": [
      "JHOS4"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_HEYA8_C.raw": {
    "Source Name": [
      "HEYA8"
    ],
    "Assay Name": [
      "HEYA8_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_HEYA8_C.raw"
    ],
    "Characteristics[CellLine]": [
      "HEYA8"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_JHOS2_C.raw": {
    "Source Name": [
      "JHOS2"
    ],
    "Assay Name": [
      "JHOS2_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_JHOS2_C.raw"
    ],
    "Characteristics[CellLine]": [
      "JHOS2"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20130619_EXQ4_FaCo_SA_CL_A2780_C.raw": {
    "Source Name": [
      "A2780"
    ],
    "Assay Name": [
      "A2780_C"
    ],
    "Raw Data File": [
      "20130619_EXQ4_FaCo_SA_CL_A2780_C.raw"
    ],
    "Characteristics[CellLine]": [
      "A2780"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_COV318_C.raw": {
    "Source Name": [
      "COV318"
    ],
    "Assay Name": [
      "COV318_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_COV318_C.raw"
    ],
    "Characteristics[CellLine]": [
      "COV318"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVCAR3_C.raw": {
    "Source Name": [
      "OVCAR3"
    ],
    "Assay Name": [
      "OVCAR3_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVCAR3_C.raw"
    ],
    "Characteristics[CellLine]": [
      "OVCAR3"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_JHOS4_B.raw": {
    "Source Name": [
      "JHOS4"
    ],
    "Assay Name": [
      "JHOS4_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_JHOS4_B.raw"
    ],
    "Characteristics[CellLine]": [
      "JHOS4"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVCAR5_B.raw": {
    "Source Name": [
      "OVCAR5"
    ],
    "Assay Name": [
      "OVCAR5_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVCAR5_B.raw"
    ],
    "Characteristics[CellLine]": [
      "OVCAR5"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVSAHO_C.raw": {
    "Source Name": [
      "OVSAHO"
    ],
    "Assay Name": [
      "OVSAHO_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVSAHO_C.raw"
    ],
    "Characteristics[CellLine]": [
      "OVSAHO"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_OVSAHO_B.raw": {
    "Source Name": [
      "OVSAHO"
    ],
    "Assay Name": [
      "OVSAHO_B"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_OVSAHO_B.raw"
    ],
    "Characteristics[CellLine]": [
      "OVSAHO"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "B"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_JHOS4_A.raw": {
    "Source Name": [
      "JHOS4"
    ],
    "Assay Name": [
      "JHOS4_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_JHOS4_A.raw"
    ],
    "Characteristics[CellLine]": [
      "JHOS4"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_CAOV3_C.raw": {
    "Source Name": [
      "CAOV3"
    ],
    "Assay Name": [
      "CAOV3_C"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_CAOV3_C.raw"
    ],
    "Characteristics[CellLine]": [
      "CAOV3"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "C"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  },
  "20150305_QEp7_FaCo_SA_CL_CAOV3_A.raw": {
    "Source Name": [
      "CAOV3"
    ],
    "Assay Name": [
      "CAOV3_A"
    ],
    "Raw Data File": [
      "20150305_QEp7_FaCo_SA_CL_CAOV3_A.raw"
    ],
    "Characteristics[CellLine]": [
      "CAOV3"
    ],
    "Characteristics[MaterialType]": [
      "cell lines"
    ],
    "Characteristics[Organism]": [
      "confirmed to be of human origin"
    ],
    "Characteristics[CleavageAgent]": [
      "LysC",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55\u2009mM iodoacetamide"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "n=3 replicates for each line"
    ],
    "Characteristics[NumberOfSamples]": [
      "Thirty cell lines were included in this study"
    ],
    "Characteristics[Temperature]": [
      "50\u2009\u00b0C"
    ],
    "Characteristics[TechnicalReplicate]": [
      "A"
    ],
    "Comment[Instrument]": [
      "Quadrupole Orbitrap mass spectrometers (Q Exactive and Q Exactive HF, Thermo Fisher Scientific, Rockford, IL, USA)"
    ],
    "Comment[AcquisitionMethod]": [
      "single-run mass spectrometric workflow",
      "A top-five method was used to select up to the five most abundant precursor ions with a charge \u22652."
    ],
    "Comment[IonizationType]": [
      "nano electrospray source"
    ],
    "Comment[FragmentationMethod]": [
      "high-energy collisional dissociation fragmentation"
    ],
    "Comment[CollisionEnergy]": [
      "25 (27 for Q Exactive HF)"
    ],
    "Comment[GradientTime]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ],
    "Comment[FlowRateChromatogram]": [
      "200\u2009nl\u2009min\u22121"
    ],
    "Comment[FractionationMethod]": [
      "absence of any fractionation step"
    ],
    "Comment[Separation]": [
      "Peptides were separated over a 250\u2009min gradient from 2% to 60% (5\u2009min to 5%, 180\u2009min to 25%, 45\u2009min to 35%, 20\u2009min to 60%) in buffer B (80% acetonitrile, 0.5% formic acid) at 200\u2009nl\u2009min\u22121."
    ]
  }
}